(19)
(11) EP 4 580 631 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23776753.8

(22) Date of filing: 30.08.2023
(51) International Patent Classification (IPC): 
A61K 31/496(2006.01)
A61K 31/519(2006.01)
A61P 35/04(2006.01)
A61K 31/506(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/496; A61K 31/506; A61K 31/519; A61P 35/00; A61P 35/04
 
C-Sets:
  1. A61K 31/496, A61K 2300/00;
  2. A61K 31/506, A61K 2300/00;
  3. A61K 31/519, A61K 2300/00;

(86) International application number:
PCT/US2023/031574
(87) International publication number:
WO 2024/049926 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 31.08.2022 US 202263402651 P
07.02.2023 US 202363443892 P
24.03.2023 US 202363454422 P
24.03.2023 US 202363454485 P
15.06.2023 US 202363508503 P

(71) Applicants:
  • Arvinas Operations, Inc.
    New Haven, CT 06511 (US)
  • Pfizer Inc.
    New York, NY 10001-2192 (US)

(72) Inventors:
  • PECK, Ronald
    Cheshire, Connecticut 06410 (US)
  • GOUGH, Sheryl Maxine
    Stratford, Connecticut 06614 (US)
  • FLANAGAN, John J.
    Guilford, Connecticut 06437 (US)
  • ANDERSON, Sibyl
    New York, New York 10039 (US)
  • TAYLOR, Ian Charles Anthony
    Madison, Connecticut 06443 (US)
  • SMITH, Julia Perkins
    New York, New York 10001-2192 (US)
  • TAN, Weiwei
    San Diego, California 92121 (US)

(74) Representative: Müller, Christian Stefan Gerd 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) DOSAGE REGIMENS OF ESTROGEN RECEPTOR DEGRADERS